Iranian Journal of Neurology 2017. 16(1):.

Multiple sclerosis: A disease on a dramatically rising trend in Iran; Review of possible reasons
Mohammad Ali Sahraian, Mohammad Sahebkar, Rouhollah Dehghani, Milad Derakhshan-Jazari, Vahid Kazami-Moghaddam, Ebrahim Kouchaki

Abstract


There has been a global rising trend in recent years in the incidence of multiple sclerosis (MS). Despite being an MS low-risk region, this disease has also been recently on the rise in the Middle East. As part of the Middle East, Iran has not been spared either; however, the cause of this dramatic increase remains to be discovered. This study reviews possible reasons for this increase in Iran. Although many factors such as the increased rate of smoking, lifestyle changes, modernization, and contact with toxic solvents can be proposed as reasons for this sudden rise in the prevalence of MS in Iran, these factors cannot be taken as definite causes and further studies are required to prove their impact.

Keywords


Multiple Sclerosis; Causality; Prevalence; Incidence; Environmental Factors; Iran

Full Text:

PDF

References


Shoenfeld Y, Selmi C, Zimlichman E, Gershwin ME (2008). The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun, 31(4): 325-30.

Eaton WW, Rose NR, Kalaydjian A, Pedersen MG, Mortensen PB (2007). Epidemiology of autoimmune diseases in Denmark. J Autoimmun,29(1):1-9.

Shoenfeld Y, Zandman-Goddard G, Stojanovich L, Cutolo M, Amital H, Levy Y, et al (2008). The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases 2008. Israel Med Assoc J, 10(1): 8.

Hewagama A, Richardson B (2009). The genetics and epigenetics of autoimmune diseases. J Autoimmun, 33(1):3.

Kivity S, Agmon-Levin N, Blank M, Shoenfeld Y (2009). Infections and autoimmunity–friends or foes?. Trends Immunol, 30(8): 409-14.

Sumelahti M-L, Hakama M, Elovaara I, Pukkala E (2010). Causes of death among patients with multiple sclerosis. Mult Scler, 16(12): 1437-42.

Ramsaransing G, De Keyser J (2006). Benign course in multiple sclerosis: a review. Acta Neurol Scan, 113(6): 359-69.

Society NMS (2003). Multiple Sclerosis Information Sourcebook. Information Resource Center and Library of the National Multiple Sclerosis Society.

Runmarker B, Andersen O (1993). Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain,116(1):117-34.

Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, et al (1989). The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain, 112 (1):133-46.

Marrie RA (2004). Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol, 3(12): 709-18.

Faridar A, Eskandari G, Sahraian MA, Minagar A, Azimi A. Vitamin D and multiple sclerosis: a critical review and recommendations on treatment. Acta Neurologica Belgica. 2012 Dec 1;112(4):327-33.

Ascherio A, Munger KL (2007). Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol, 61(6): 504-13.

Sahraian MA, Pakdaman H, Harandi AA. Is it time to revise the classification of geographical distribution of multiple sclerosis?. Iranian journal of neurology. 2012;11(2):77.

Aljumah M, Alroughani R, Alsharoqi I, Bohlega SA, Dahdaleh M, Deleu D, Esmat K, Khalifa A, Sahraian MA, Szólics M, AlTahan A. Future of management of multiple sclerosis in the middle East: a consensus view from specialists in ten countries. Multiple sclerosis international. 2013 Dec 17;2013.

Organization WH (2008). Atlas: multiple sclerosis resources in the world.

Aljumah M, Alroughani R, Alsharoqi I, Bohlega SA, Dahdaleh M, Deleu D, et al (2013). Future of Management of Multiple Sclerosis in the Middle East: A Consensus View from Specialists in Ten Countries. Mult Scler Int.

Inshasi J, Thakre M (2011). Prevalence of multiple sclerosis in Dubai, United Arab Emirates. Int J Neurosci,121(7): 393-8.

Al-Hashel J, Besterman AD, Wolfson C (2008). The prevalence of multiple sclerosis in the Middle East. Neuroepidemiology, 31(2): 129-37.

Bohlega S, Inshasi J, Al Tahan AR, Madani AB, Qahtani H, Rieckmann P (2013). Multiple sclerosis in the Arabian Gulf countries: a consensus statement. J Neurol, 260(12): 2959-63.

Al-Araji A, Mohammed AI (2005). Multiple sclerosis in Iraq: does it have the same features encountered in Western countries?. J Neurol Sci, 234(1): 67-71.

Yamout B, Barada W, Tohme R, Mehio-Sibai A, Khalifeh R, El-Hajj T (2008). Clinical characteristics of multiple sclerosis in Lebanon. J Neurol Sci, 270(1): 88-93.

El-Salem K, Al-Shimmery E, Horany K, Al-Refai A, Al-Hayk K, Khader Y (2006). Multiple sclerosis in Jordan: a clinical and epidemiological study. J Neurol, 253(9): 1210-6.

Radhakrishnan K, Ashok P, Sridharan R, Mousa M (1985). Prevalence and pattern of multiple sclerosis in Benghazi, north-eastern Libya. J Neurol Sci, 70(1): 39-46.

Tharakan JJ, Chand RP, Jacob PC (2005). Multiple sclerosis in Oman. Neurosciences (Riyadh, Saudi Arabia), 10(3): 223-5.

Romdhane NA, Ben Hamida M, Mrabet A, Larnaout A, Samoud S, Ben Hamda A, et al (1993). Prevalence study of neurologic disorders in Kelibia (Tunisia). Neuroepidemiology, 12(5): 285-99.

Dehghani R, Yunesian M, Sahraian MA, Gilasi HR, Kazemi moghaddam V (2015). The evaluation of MS dispersal in Iran and its correlation with urbanization, life style and industry. Iran J Public Health, 44(6): 830-838.

Izadi S, Nikseresht A, Sharifian M, Sahraian MA, Jahromi AH, Aghighi M, Heidary A. Significant increase in the prevalence of multiple sclerosis in iran in 2011. Iranian journal of medical sciences. 2014 Mar;39(2):152.

Sahraian MA, Khorramnia S, Ebrahim MM, Moinfar Z, Lotfi J, Pakdaman H (2010). Multiple sclerosis in Iran: a demographic study of 8,000 patients and changes over time. Eur Neurol, 64(6): 331-6.

Moghtaderi A, Rakhshanizadeh F, Shahraki-Ibrahimi S (2013). Incidence and prevalence of multiple sclerosis in southeastern Iran. Clin Neurol Neurosurg, 115(3): 304-8.

Etemadifar M, Abtahi S-H (2012). Multiple Sclerosis in Isfahan: past, present and future. Int J Prev Med, 3(5).

Tunstall-Pedoe H (2006). Preventing Chronic Diseases. A Vital Investment: WHO Global Report. Geneva: World Health Organization, 2005. pp 200. CHF 30.00. ISBN 92 4 1563001. Also published on http://www. who. int/chp/chronic_disease_report/en. Int J Epidemiol, 35(4): 1107.

Buckley L, Bushart S, Efremenkov V, Karlin Y, Kohout R, Pabby A, et al (2004). Application of Membrane Technologies for Liquid Radioactive Waste Processing. IAEA-TRS No 431, 145 p.

Ghassemi H, Harrison G, Mohammad K (2002). An accelerated nutrition transition in Iran. Public Health Nut, 5(1a): 149-55.

Pekmezovic T, Drulovic J, Milenkovic M, Jarebinski M, Stojsavljevic N, Mesaros S, et al (2006). Lifestyle factors and multiple sclerosis: A case-control study in Belgrade. Neuroepidemiology, 27(4): 212-6.

Dehghani R, Zarghi I, Hajijafari T, Falahnia M, Hosseni M (2013). investigation into level of iodine in Market iodized salt in Kashan, 2010. Journal of North Khorasan University of Medical Sciences, 5(3): 559.

Harandi AA, Harandi AA, Pakdaman H, Sahraian MA. Vitamin D and multiple sclerosis. Iranian journal of neurology. 2014;13(1):1

Kazemisaleh D, Jozanikohan Z, Assar O, Lotfian I (2013). The effect of vitamin D deficiency on coronary artery stenosis severity in an gioplasty patients in Baqiatallah hospital in 2013. Arak Medical University Journal (AMUJ), 16(79): 70-5.

Smolders J, Peelen E, Thewissen M, Menheere P, Cohen Tervaert JW, Hupperts R, et al (2009). The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun Rev, 8(7): 621-6.

Holick MF(2007). Vitamin D deficiency. N Engl J Med, 357(3): 266-81.

Fields J, Trivedi NJ, Horton E, Mechanick JI (2011). Vitamin D in the Persian Gulf: integrative physiology and socioeconomic factors. Curr Osteoporos Rep, 9(4): 243-50.

dehghani r, takht firozeh m, yeganeh m, meghdadi m, mosavi g, haji bagheri a, et al (2013). Cigarette Smoking Status in The City of Ardestan City During 2010. journal of ilam university of medical sciences, 21(4): 75-82.

Dehghani R, Yunesian M, Sahraian M, Gilasi H, Danesh Pazhooh F, Kazemi Moghaddam V (2014). The Relationship between Lifestyle and Prevalence of Multiple Sclerosis in Iran: An Ecological Study in2011. Community Health Journal, 8 (1) : 63-72

Riise T, Nortvedt MW, Ascherio A (2003). Smoking is a risk factor for multiple sclerosis. Neurology, 61(8): 1122-4.

Maghzi A, Ghazavi H, Ahsan M, Etemadifar M, Mousavi S, Khorvash F, et al (2010). Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based study. Mult Scler Int, 16(3): 359-61.

Rubin D, Leventhal J, Krasilnikoff P, Weile B, Berget A (1986). Effect of passive smoking on birth-weight. Lancet, 328(8504): 415-7.

Sundström P, Nyström L, Hallmans G (2008). Smoke exposure increases the risk for multiple sclerosis. Eur J Neurol, 15(6): 579-83.

Non-Communicable Disease Risk Factor InfoBase [database on the Internet]. Islamic Republic of IRAN - Ministry of Health & Medical Education - Undersecretary for Health - Center for Disease Management (2009). Available from: http://www.ncdinfobase.ir/english/.

Dehghani R, Takht Firuze M, Yeganeh M, Meqdadi M, Musavi G, editors (2013). Study of cigarette smoking in the Ardestan in 2011. The Sixteenth Iranian National Conference on Environmental Health, Tabriz university of medical sciences.

Kelishadi R, Poursafa P (2010). Air pollution and non-respiratory health hazards for children. Arch Med Sci, 6(4):483-95.

Gregory II AC, Shendell DG, Okosun IS, Gieseker KE (2008). Multiple Sclerosis disease distribution and potential impact of environmental air pollutants in Georgia. Sci Total Environ, 396(1):42-51.

Heydarpour P, Amini H, Khoshkish S, Seidkhani H, Sahraian MA, Yunesian M. Potential impact of air pollution on multiple sclerosis in Tehran, Iran. Neuroepidemiology. 2014;43(3-4):233-8.

Talebi S, Tavakoli T, Ghinani A (2008). Levels of PM10 and its chemical composition in the atmosphere of the city of Isfahan. Iran J Chem Engin, 3:62-7.

Halek F, Kavouci A, Montehaie H (2004). Role of motor-vehicles and trend of air borne particulate in the Great Tehran area, Iran. Int J Environ Res, 14(4):307-13.

Dehghani R, Takht Firuze M, Hossein Dust G, Mosayiebi M, editors (2013). Survey of air quality health based on air quality index in Kashan 2012. The Sixteenth Iranian National Conference on Environmental Health, Tabriz university of medical sciences.

Dehghani R(2014). Human ,Environment and Disease. Kashan University of Medical Sciences: Publications of Farmanesh , 1-485.

Bølviken B, Celius E, Nilsen R, Strand T(2003). Radon: a possible risk factor in multiple sclerosis. Neuroepidemiology, 22(1): 87-94.

Dehghani R, Fathabadi N, Kardan M, Mohammadi M, Atoof F(2013). Survey of Gamma Dose and Radon Exhalation Rate from Soil Surface of High Background Natural Radiation Areas in Ramsar, Iran. Zahedan Journal of Research in Medical Sciences, 15(9):81-4.

Fathabadi N, Mohammadi M, Dehghani R, Kardan MR, Atoof F, Vashghani Farahani M, et al (2013). The Effects of Environmental Parameters on the Radon Exhalation Rate from the ground Surface in HBRA in Ramsar with a Regression Model. Life Sci J, 10(5): 563-9.

Riise T, Moen BE, Kyvik KR (2002). Organic solvents and the risk of multiple sclerosis. Epidemiology, 13(6):718-20.

Mortensen JT, Bronnum-Hansen H, Rasmussen K (1998). Multiple sclerosis and organic solvents. Epidemiology, 9(2):168-71.

Koch MW, Metz LM, Agrawal SM, Yong VW (2013). Environmental factors and their regulation of immunity in multiple sclerosis. J Neurol Sci, 324(1):10-6.

Dehghani R (2010). Environmental Toxicology. 1ed st. Kashan University of Medical Science Takderakht.

Dehghani R (2014). Human, Environment and Disease. Kashan University of Medical Science. Farmanesh.

Dehghani R, Sabahi Bidgoli M, Asgari Arani J, Rashedi Vahed G.H, Heydari F, Afshari N (2012). A Survey on the application and storage conditions of pesticides in Kashan, Iran. 2(1)54-59.

Dehghani R, Limoee M, Zarghi I (2012). The review of pesticide hazards with emphasis on insecticide resistance in arthropods of health risk importance. Scientific Journal of Kurdistan University of Medical Sciences, 17(1):82-98.

Dehghani R, Moosavi SG, Esalmi H, Mohammadi M, Jalali Z, Zamini N (2011). Surveying of pesticides commonly on the markets of Iran in 2009. Journal of Environmental Protection, 2(8): 1113.


Refbacks

  • There are currently no refbacks.


Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.